International Journal of Cardiovascular Sciences. 15/Aug/2025;38:e20250035.
Transcatheter Bicaval Valve System in the Treatment of Torrential Tricuspid Regurgitation and Refractory Systemic Hypervolemia: 12-Month Outcome
Rômulo Francisco de Almeida Torres
, Alessandro Kraemer
, Rafael de Almeida Torres
, Fernanda Proença Lepca Bozzi
, Sarah Fagundes Grobe
, Eduardo Mendel Balbi Filho
, Guilherme Barreto Gameiro Silva
Abstract
Severe isolated tricuspid regurgitation (TR) is associated with limiting symptoms, negative impact on quality of life, and poor prognosis. The TricValve® device is a transcatheter self-expanding biological valve system designed to mitigate systemic volume overload, improve quality of life, and improve congestive symptoms. We report a 12-month follow-up of a 61-year-old woman with signs of refractory systemic hypervolemia and torrential TR who underwent the procedure. The treatment resulted in significant weight loss, improvement in signs of hypervolemia, and improvement in functional class (FC).
75
